Allergan, Merz Row Over Botox Secrets Headed To Trial

Law360, Los Angeles (January 30, 2012, 7:34 PM EST) -- A California federal judge on Monday indicated that Merz Pharmaceuticals LLC and seven of its employees would have to defend themselves against allegations by Allergan Inc. that they used proprietary sales data for the wrinkle-reducing drug Botox to snag clients for a rival drug.

U.S. District Judge Andrew J. Guilford suggested in a tentative ruling that he would keep mostly intact Allergan's lawsuit, which alleges that several former employees tasked with marketing Botox copied thousands of confidential documents, including the company's proprietary sales and client data,...
To view the full article, register now.




Case Information

Case Title

Allergan Inc v. Merz Pharmaceuticals LLC et al

Case Number



California Central

Nature of Suit

Labor: Other


Andrew J. Guilford

Date Filed

March 18, 2011

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.